首页> 外文期刊>Stem cells international >N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate
【24h】

N6-Methyladenosine in RNA and DNA: An Epitranscriptomic and Epigenetic Player Implicated in Determination of Stem Cell Fate

机译:在RNA和DNA中的N6-甲基腺苷:癫痫组和表观遗传症的测定含有epItrancemic和表观遗传杂志

获取原文
获取原文并翻译 | 示例
           

摘要

Vast emerging evidences are linking the base modifications and determination of stem cell fate such as proliferation and differentiation. Among the base modification markers extensively studied, 5-methylcytosine (5-mC) and its oxidative derivatives (5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC)) dynamically occur in DNA and RNA and have been acknowledged as important epigenetic markers involved in regulation of cellular biological processes. N6-Methyladenosine modification in DNA (m6dA), mRNA (m6A), tRNA, and other noncoding RNAs has been defined as another important epigenetic and epitranscriptomic marker in eukaryotes in recent years. The mRNA m6A modification has been characterized biochemically, molecularly, and phenotypically, including elucidation of its methyltransferase complexes (m6A writer), demethylases (m6A eraser), and direct interaction proteins (readers), while limited information on the DNA m6dA is available. The levels and the landscapes of m6A in the epitranscriptomes and epigenomes are precisely and dynamically regulated by the fine-tuned coordination of the writers and erasers in accordance with stages of the growth, development, and reproduction as naturally programmed during the lifespan. Additionally, progress has been made in appreciation of the link between aberrant m6A modification in stem cells and diseases, like cancers and neurodegenerative disorders. These achievements are inspiring scientists to further uncover the epigenetic mechanisms for stem cell development and to dissect pathogenesis of the multiple diseases conferred by development aberration of the stem cells. This review article will highlight the research advances in the role of m6A methylation modifications of DNA and RNA in the regulation of stem cell and genesis of the closely related disorders. Additionally, this article will also address the research directions in the future.
机译:巨大的新兴证明是将基础修改和测定与诸如增殖和分化等诸如增殖和分化的基础修改和测定。在基础修饰标志物中,动态地研究了5-甲基胞嘧啶(5-MC)和其氧化衍生物(5-羟甲基胞嘧啶(5-HMC),5-甲酰键菌(5-FC)和5-羧基胞嘧啶(5-CAC))在DNA和RNA中发生,并且已被视为参与细胞生物学过程调节的重要表观遗传标志物。 DNA(M6DA),mRNA(M6A),TRNA和其他非编码RNA中的N6-甲基腺苷修饰已被定义为近年来真核生物中的另一个重要表观遗传和ePIGRASEMIC标志物。 MRNA M6A修饰已经表征生物化学,分子和表型,包括甲基转移酶络合物(M6A作家),去甲基酶(M6A橡皮擦)和直接相互作用蛋白(读数器)的阐明,而DNA M6DA的有限信息可用。通过在寿命期间的生长,开发和繁殖的阶段,ePitrAstcriptomes和表观蛋白中M6a的水平和景观恰好和动态地调节作者和橡皮擦的微调协调。另外,鉴于干细胞和疾病中的异常M6a改性之间的联系,如癌症和神经变性障碍的联系。这些成就鼓励科学家进一步揭示干细胞发育的表观遗传机制,并通过干细胞的发育畸变筛选赋予赋予的多种疾病的发病机制。本综述文章将突出DNA和RNA在干细胞调节中的M6A甲基化修饰的作用以及密切相关疾病的起源的研究进展。此外,本文还将在未来解决研究方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号